Soliton with ticker code (SOLY) have now 3 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 22 and 12 calculating the average target price we see 16. Given that the stocks previous close was at 8.37 this would indicate that there is a potential upside of 91.2%. The day 50 moving average is 8.4 and the 200 day MA is 8.22. The company has a market cap of $177m. Visit the company website at: http://www.soliton.com
The potential market cap would be $338m based on the market concensus.
Soliton, a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers product for the removal of tattoos. It also develops product for cellulite reduction, fibrotic scar treatment, and other indications. The company was founded in 2012 and is based in Houston, Texas.
